SCHEMBL4636268

SCHEMBL4636268

Cc1cn2ccccc2c1C(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.49
KDM4E B2RXH2 9/20 0.49
MEN1 O00255 7/20 0.49
KMT2A Q03164 7/20 0.49
HPGD P15428 6/20 0.49
GAA P10253 4/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HTT P42858 2/20 0.44
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
ATM Q13315 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597471 0.86 KDM4E (0.55) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL25169306 0.81 KDM4E (0.47) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL27478028 0.79 ALDH1A1 (0.62) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL28574939 0.78 KDM4E (0.51) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL26415091 0.76 KDM4E (0.71) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30039651 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30039822 0.76 POLB (0.44) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL17477689 0.71 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL9518821 0.70 ALDH1A1 (0.65) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL9518758 0.70 KDM4E (0.56) ALDH1A1KDM4EMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 US disclosed
EP-1931663-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR Argenta Discovery Limited (GB) 2008-06-18 EP disclosed
WO-2007031747-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR ARGENTA DISCOVERY LIMITED (GB) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor HRH4, HRH2, HRH3 ALDH1A1 3463/4885KDM4E 4771/4885MEN1 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.